APO Research
Talk to an analyst

APO RESEARCH · REPORT

Intravenous Solutions

Intravenous Solutions is the infusion of liquid substances directly into a vein. Therapies administered intravenously are often included in the designation of specialty drugs. Intravenous infusions are commonly referred to as drips because many systems of administration employ a drip chamber, which prevents air from entering the blood stream (air embolism), and allows an estimation of flow rate.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Intravenous Solutions is the infusion of liquid substances directly into a vein. Therapies administered intravenously are often included in the designation of specialty drugs. Intravenous infusions are commonly referred to as drips because many systems of administration employ a drip chamber, which prevents air from entering the blood stream (air embolism), and allows an estimation of flow rate.

Selected research

Market Outlook & Growth Opportunities

Global Intravenous Solutions Market Outlook and Growth Opportunities 2026

21 December 2025194 pages

Choose your research edition.

Industry ResearchIntravenous Solutions Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Intravenous Solutions Industry Growth and Trends Forecast to 203291 pages · $3,450 USDMarket StructureGlobal Intravenous Solutions Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032183 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Intravenous Solutions Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Intravenous Solutions Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

Intravenous Solutions is the infusion of liquid substances directly into a vein. Therapies administered intravenously are often included in the designation of specialty drugs. Intravenous infusions are commonly referred to as drips because many systems of administration employ a drip chamber, which prevents air from entering the blood stream (air embolism), and allows an estimation of flow rate.

Global Intravenous Solutions key players include Baxter, Kelun Group, Fresenius Kabi, etc. Global top three manufacturers hold a share over 35%.

Asia-Pacific is the largest market, with a share over 45%, followed by Europe, and North America, both have a share over 40 percent.

Read the full market overview

In terms of product, Crystalloids is the largest segment, with a share over 75%. And in terms of application, the largest application is Basic IV Solutions, followed by Nutrient Infusion Solution, etc.

This report provides an overview of the global Intravenous Solutions market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Intravenous Solutions and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Intravenous Solutions sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Intravenous Solutions market size, projected growth trends, production technologies, key applications, and end-use industries.

Intravenous Solutions Segment by Company

Baxter

Kelun Group

Fresenius Kabi

Otsuka

ICU Medical

Fresenius Kabi

JW Life Science

B. Braun Melsungen

Intravenous Solutions Segment by Type

Crystalloids

Colloids

Others

Intravenous Solutions Segment by Application

Basic IV Solutions

Nutrient Infusion Solution

Others

Intravenous Solutions Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Intravenous Solutions status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Intravenous Solutions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Intravenous Solutions significant trends, drivers, influence factors in global and regions.

6. To analyze Intravenous Solutions competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Intravenous Solutions market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Intravenous Solutions and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Intravenous Solutions.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Intravenous Solutions market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Intravenous Solutions industry.

Chapter 3: Detailed analysis of Intravenous Solutions manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Intravenous Solutions in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Intravenous Solutions in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Intravenous Solutions Industry Trends Table 2. Intravenous Solutions Industry Drivers Table 3. Intravenous Solutions Industry Opportunities and Challenges Table 4. Intravenous Solutions Industry Restraints Table 5. Global Intravenous Solutions Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Intravenous Solutions Revenue Share by Company (2021-2026) Table 7. Global Intravenous Solutions Sales Volume by Company (M Units) & (2021-2026) Table 8. Global Intravenous Solutions Sales Volume Share by Company (2021-2026) Table 9. Global Intravenous Solutions Average Price (US$/K Unit) of Company (2021-2026) Table 10. Global Intravenous Solutions Company Ranking, (2024-2026) & (USD Million) Table 11. Global Intravenous Solutions Key Company Manufacturing Base & Headquarters Table 12. Global Intravenous Solutions Company, Product Type & Application Table 13. Global Intravenous Solutions Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Intravenous Solutions by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Crystalloids Table 18. Significant Companies of Colloids Table 19. Significant Companies of Others Table 20. Global Intravenous Solutions Sales Volume by Type 2021 VS 2025 VS 2032 (M Units) Table 21. Global Intravenous Solutions Sales Volume by Type (2021-2026) & (M Units) Table 22. Global Intravenous Solutions Sales Volume by Type (2027-2032) & (M Units) Table 23. Global Intravenous Solutions Sales Volume Share by Type (2021-2026) Table 24. Global Intravenous Solutions Sales Volume Share by Type (2027-2032) Table 25. Global Intravenous Solutions Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Intravenous Solutions Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Intravenous Solutions Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Intravenous Solutions Sales Value Share by Type (2021-2026) Table 29. Global Intravenous Solutions Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Basic IV Solutions Table 31. Significant Companies of Nutrient Infusion Solution Table 32. Significant Companies of Others Table 33. Global Intravenous Solutions Sales Volume by Application 2021 VS 2025 VS 2032 (M Units) Table 34. Global Intravenous Solutions Sales Volume by Application (2021-2026) & (M Units) Table 35. Global Intravenous Solutions Sales Volume by Application (2027-2032) & (M Units) Table 36. Global Intravenous Solutions Sales Volume Share by Application (2021-2026) Table 37. Global Intravenous Solutions Sales Volume Share by Application (2027-2032) Table 38. Global Intravenous Solutions Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Intravenous Solutions Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Intravenous Solutions Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Intravenous Solutions Sales Value Share by Application (2021-2026) Table 42. Global Intravenous Solutions Sales Value Share by Application (2027-2032) Table 43. Global Intravenous Solutions Sales by Region: 2021 VS 2025 VS 2032 (M Units) Table 44. Global Intravenous Solutions Sales by Region (2021-2026) & (M Units) Table 45. Global Intravenous Solutions Sales Market Share by Region (2021-2026) Table 46. Global Intravenous Solutions Sales by Region (2027-2032) & (M Units) Table 47. Global Intravenous Solutions Sales Market Share by Region (2027-2032) Table 48. Global Intravenous Solutions Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Intravenous Solutions Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Intravenous Solutions Sales Value Share by Region (2021-2026) Table 51. Global Intravenous Solutions Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Intravenous Solutions Sales Value Share by Region (2027-2032) Table 53. Global Intravenous Solutions Market Average Price (US$/K Unit) by Region (2021-2026) Table 54. Global Intravenous Solutions Market Average Price (US$/K Unit) by Region (2027-2032) Table 55. Global Intravenous Solutions Sales by Country: 2021 VS 2025 VS 2032 (M Units) Table 56. Global Intravenous Solutions Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Intravenous Solutions Sales by Country (2021-2026) & (M Units) Table 58. Global Intravenous Solutions Sales Market Share by Country (2021-2026) Table 59. Global Intravenous Solutions Sales by Country (2027-2032) & (M Units) Table 60. Global Intravenous Solutions Sales Market Share by Country (2027-2032) Table 61. Global Intravenous Solutions Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Intravenous Solutions Sales Value Market Share by Country (2021-2026) Table 63. Global Intravenous Solutions Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Intravenous Solutions Sales Value Market Share by Country (2027-2032) Table 65. Baxter Company Information Table 66. Baxter Business Overview Table 67. Baxter Intravenous Solutions Sales (M Units), Value (US$ Million), Price (US$/K Unit) and Gross Margin (2021-2026) Table 68. Baxter Intravenous Solutions Product Portfolio Table 69. Baxter Recent Development Table 70. Kelun Group Company Information Table 71. Kelun Group Business Overview Table 72. Kelun Group Intravenous Solutions Sales (M Units), Value (US$ Million), Price (US$/K Unit) and Gross Margin (2021-2026) Table 73. Kelun Group Intravenous Solutions Product Portfolio Table 74. Kelun Group Recent Development Table 75. Fresenius Kabi Company Information Table 76. Fresenius Kabi Business Overview Table 77. Fresenius Kabi Intravenous Solutions Sales (M Units), Value (US$ Million), Price (US$/K Unit) and Gross Margin (2021-2026) Table 78. Fresenius Kabi Intravenous Solutions Product Portfolio Table 79. Fresenius Kabi Recent Development Table 80. Otsuka Company Information Table 81. Otsuka Business Overview Table 82. Otsuka Intravenous Solutions Sales (M Units), Value (US$ Million), Price (US$/K Unit) and Gross Margin (2021-2026) Table 83. Otsuka Intravenous Solutions Product Portfolio Table 84. Otsuka Recent Development Table 85. ICU Medical Company Information Table 86. ICU Medical Business Overview Table 87. ICU Medical Intravenous Solutions Sales (M Units), Value (US$ Million), Price (US$/K Unit) and Gross Margin (2021-2026) Table 88. ICU Medical Intravenous Solutions Product Portfolio Table 89. ICU Medical Recent Development Table 90. Fresenius Kabi Company Information Table 91. Fresenius Kabi Business Overview Table 92. Fresenius Kabi Intravenous Solutions Sales (M Units), Value (US$ Million), Price (US$/K Unit) and Gross Margin (2021-2026) Table 93. Fresenius Kabi Intravenous Solutions Product Portfolio Table 94. Fresenius Kabi Recent Development Table 95. JW Life Science Company Information Table 96. JW Life Science Business Overview Table 97. JW Life Science Intravenous Solutions Sales (M Units), Value (US$ Million), Price (US$/K Unit) and Gross Margin (2021-2026) Table 98. JW Life Science Intravenous Solutions Product Portfolio Table 99. JW Life Science Recent Development Table 100. B. Braun Melsungen Company Information Table 101. B. Braun Melsungen Business Overview Table 102. B. Braun Melsungen Intravenous Solutions Sales (M Units), Value (US$ Million), Price (US$/K Unit) and Gross Margin (2021-2026) Table 103. B. Braun Melsungen Intravenous Solutions Product Portfolio Table 104. B. Braun Melsungen Recent Development Table 105. Key Raw Materials Table 106. Raw Materials Key Suppliers Table 107. Intravenous Solutions Distributors List Table 108. Intravenous Solutions Customers List Table 109. Research Programs/Design for This Report Table 110. Authors List of This Report Table 111. Secondary Sources Table 112. Primary Sources List of Figures Figure 1. Intravenous Solutions Product Image Figure 2. Global Intravenous Solutions Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Intravenous Solutions Sales Value (2021-2032) & (US$ Million) Figure 4. Global Intravenous Solutions Sales (2021-2032) & (M Units) Figure 5. Global Intravenous Solutions Sales Average Price (US$/K Unit) & (2021-2032) Figure 6. Global Intravenous Solutions Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Crystalloids Image Figure 10. Colloids Image Figure 11. Others Image Figure 12. Global Intravenous Solutions Sales Volume by Type (2021 VS 2025 VS 2032) & (M Units) Figure 13. Global Intravenous Solutions Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Intravenous Solutions Sales Volume Share by Type (2021-2032) Figure 15. Global Intravenous Solutions Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Intravenous Solutions Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Intravenous Solutions Sales Value Share by Type (2021-2032) Figure 18. Basic IV Solutions Image Figure 19. Nutrient Infusion Solution Image Figure 20. Others Image Figure 21. Global Intravenous Solutions Sales Volume by Application (2021 VS 2025 VS 2032) & (M Units) Figure 22. Global Intravenous Solutions Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Intravenous Solutions Sales Volume Share by Application (2021-2032) Figure 24. Global Intravenous Solutions Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Intravenous Solutions Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Intravenous Solutions Sales Value Share by Application (2021-2032) Figure 27. Global Intravenous Solutions Sales by Region: 2021 VS 2025 VS 2032 (M Units) Figure 28. Global Intravenous Solutions Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Intravenous Solutions Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Intravenous Solutions Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Intravenous Solutions Sales Value (2021-2032) & (US$ Million) Figure 32. North America Intravenous Solutions Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Intravenous Solutions Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Intravenous Solutions Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Intravenous Solutions Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Intravenous Solutions Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Intravenous Solutions Sales Value (2021-2032) & (US$ Million) Figure 38. South America Intravenous Solutions Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Intravenous Solutions Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Intravenous Solutions Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Intravenous Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Intravenous Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Intravenous Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Intravenous Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Intravenous Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Intravenous Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Intravenous Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Intravenous Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Intravenous Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Intravenous Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Intravenous Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Intravenous Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Intravenous Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Intravenous Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Intravenous Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Intravenous Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Intravenous Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Intravenous Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Intravenous Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Intravenous Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Intravenous Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Intravenous Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Intravenous Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Intravenous Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Intravenous Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Intravenous Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Intravenous Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Intravenous Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Intravenous Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Intravenous Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Intravenous Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Intravenous Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Intravenous Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Intravenous Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Intravenous Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Intravenous Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Intravenous Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Intravenous Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Intravenous Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Intravenous Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Intravenous Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Intravenous Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Intravenous Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Intravenous Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Intravenous Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Intravenous Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Intravenous Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Intravenous Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Intravenous Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Intravenous Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Intravenous Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Intravenous Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Intravenous Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Intravenous Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Intravenous Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Intravenous Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Intravenous Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Intravenous Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Intravenous Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Intravenous Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Intravenous Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Intravenous Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Intravenous Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Intravenous Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Intravenous Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Intravenous Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Intravenous Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Intravenous Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Intravenous Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Intravenous Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Intravenous Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Intravenous Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Intravenous Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Intravenous Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Intravenous Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Intravenous Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Intravenous Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Intravenous Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Intravenous Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Intravenous Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Intravenous Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Intravenous Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Intravenous Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Intravenous Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Intravenous Solutions Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Intravenous Solutions Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • Crystalloids
  • Colloids
  • Others
Applications
  • Basic IV Solutions
  • Nutrient Infusion Solution
  • Others
Companies covered
  • Baxter
  • Kelun Group
  • Fresenius Kabi
  • Otsuka
  • ICU Medical
  • Fresenius Kabi
  • JW Life Science
  • B. Braun Melsungen

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Intravenous Solutions Sales Value (2021-2032)
  4. 1.2.2 Global Intravenous Solutions Sales Volume (2021-2032)
  5. 1.2.3 Global Intravenous Solutions Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Intravenous Solutions Market Dynamics
  1. 2.1 Intravenous Solutions Industry Trends
  2. 2.2 Intravenous Solutions Industry Drivers
  3. 2.3 Intravenous Solutions Industry Opportunities and Challenges
  4. 2.4 Intravenous Solutions Industry Restraints
3 Intravenous Solutions Market by Company
  1. 3.1 Global Intravenous Solutions Company Revenue Ranking in 2025
  2. 3.2 Global Intravenous Solutions Revenue by Company (2021-2026)
  3. 3.3 Global Intravenous Solutions Sales Volume by Company (2021-2026)
  4. 3.4 Global Intravenous Solutions Average Price by Company (2021-2026)
  5. 3.5 Global Intravenous Solutions Company Ranking (2024-2026)
  6. 3.6 Global Intravenous Solutions Company Manufacturing Base and Headquarters
  7. 3.7 Global Intravenous Solutions Company Product Type and Application
  8. 3.8 Global Intravenous Solutions Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Intravenous Solutions Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Intravenous Solutions Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Intravenous Solutions Market by Type
  1. 4.1 Intravenous Solutions Type Introduction
  2. 4.1.1 Crystalloids
  3. 4.1.2 Colloids
  4. 4.1.3 Others
  5. 4.2 Global Intravenous Solutions Sales Volume by Type
  6. 4.2.1 Global Intravenous Solutions Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Intravenous Solutions Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Intravenous Solutions Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Intravenous Solutions Sales Value by Type
  10. 4.3.1 Global Intravenous Solutions Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Intravenous Solutions Sales Value by Type (2021-2032)
  12. 4.3.3 Global Intravenous Solutions Sales Value Share by Type (2021-2032)
5 Intravenous Solutions Market by Application
  1. 5.1 Intravenous Solutions Application Introduction
  2. 5.1.1 Basic IV Solutions
  3. 5.1.2 Nutrient Infusion Solution
  4. 5.1.3 Others
  5. 5.2 Global Intravenous Solutions Sales Volume by Application
  6. 5.2.1 Global Intravenous Solutions Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Intravenous Solutions Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Intravenous Solutions Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Intravenous Solutions Sales Value by Application
  10. 5.3.1 Global Intravenous Solutions Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Intravenous Solutions Sales Value by Application (2021-2032)
  12. 5.3.3 Global Intravenous Solutions Sales Value Share by Application (2021-2032)
6 Intravenous Solutions Regional Sales and Value Analysis
  1. 6.1 Global Intravenous Solutions Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Intravenous Solutions Sales by Region (2021-2032)
  3. 6.2.1 Global Intravenous Solutions Sales by Region: 2021-2026
  4. 6.2.2 Global Intravenous Solutions Sales by Region (2027-2032)
  5. 6.3 Global Intravenous Solutions Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Intravenous Solutions Sales Value by Region (2021-2032)
  7. 6.4.1 Global Intravenous Solutions Sales Value by Region: 2021-2026
  8. 6.4.2 Global Intravenous Solutions Sales Value by Region (2027-2032)
  9. 6.5 Global Intravenous Solutions Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Intravenous Solutions Sales Value (2021-2032)
  12. 6.6.2 North America Intravenous Solutions Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Intravenous Solutions Sales Value (2021-2032)
  15. 6.7.2 Europe Intravenous Solutions Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Intravenous Solutions Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Intravenous Solutions Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Intravenous Solutions Sales Value (2021-2032)
  21. 6.9.2 South America Intravenous Solutions Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Intravenous Solutions Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Intravenous Solutions Sales Value Share by Country, 2025 VS 2032
7 Intravenous Solutions Country-level Sales and Value Analysis
  1. 7.1 Global Intravenous Solutions Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Intravenous Solutions Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Intravenous Solutions Sales by Country (2021-2032)
  4. 7.3.1 Global Intravenous Solutions Sales by Country (2021-2026)
  5. 7.3.2 Global Intravenous Solutions Sales by Country (2027-2032)
  6. 7.4 Global Intravenous Solutions Sales Value by Country (2021-2032)
  7. 7.4.1 Global Intravenous Solutions Sales Value by Country (2021-2026)
  8. 7.4.2 Global Intravenous Solutions Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Intravenous Solutions Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Intravenous Solutions Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Intravenous Solutions Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Intravenous Solutions Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Intravenous Solutions Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Intravenous Solutions Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Intravenous Solutions Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Intravenous Solutions Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Intravenous Solutions Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Intravenous Solutions Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Intravenous Solutions Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Intravenous Solutions Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Intravenous Solutions Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Intravenous Solutions Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Intravenous Solutions Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Intravenous Solutions Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Intravenous Solutions Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Intravenous Solutions Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Intravenous Solutions Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Intravenous Solutions Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Intravenous Solutions Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Intravenous Solutions Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Intravenous Solutions Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Intravenous Solutions Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Intravenous Solutions Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Intravenous Solutions Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Intravenous Solutions Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Intravenous Solutions Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Intravenous Solutions Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Intravenous Solutions Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Intravenous Solutions Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Intravenous Solutions Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Intravenous Solutions Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Intravenous Solutions Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Intravenous Solutions Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Intravenous Solutions Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Intravenous Solutions Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Intravenous Solutions Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Intravenous Solutions Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Intravenous Solutions Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Intravenous Solutions Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Intravenous Solutions Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Intravenous Solutions Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Intravenous Solutions Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Intravenous Solutions Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Intravenous Solutions Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Intravenous Solutions Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Intravenous Solutions Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Intravenous Solutions Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Intravenous Solutions Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Intravenous Solutions Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Intravenous Solutions Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Intravenous Solutions Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Intravenous Solutions Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Intravenous Solutions Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Intravenous Solutions Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Intravenous Solutions Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Intravenous Solutions Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Intravenous Solutions Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Intravenous Solutions Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Intravenous Solutions Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Intravenous Solutions Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Intravenous Solutions Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Intravenous Solutions Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Intravenous Solutions Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Intravenous Solutions Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Intravenous Solutions Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Intravenous Solutions Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Intravenous Solutions Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Intravenous Solutions Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Intravenous Solutions Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Intravenous Solutions Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Intravenous Solutions Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Intravenous Solutions Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Intravenous Solutions Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Intravenous Solutions Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Intravenous Solutions Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Intravenous Solutions Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Intravenous Solutions Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Intravenous Solutions Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Intravenous Solutions Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Intravenous Solutions Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Intravenous Solutions Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Intravenous Solutions Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Baxter
  2. 8.1.1 Baxter Company Information
  3. 8.1.2 Baxter Business Overview
  4. 8.1.3 Baxter Intravenous Solutions Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Baxter Intravenous Solutions Product Portfolio
  6. 8.1.5 Baxter Recent Developments
  7. 8.2 Kelun Group
  8. 8.2.1 Kelun Group Company Information
  9. 8.2.2 Kelun Group Business Overview
  10. 8.2.3 Kelun Group Intravenous Solutions Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Kelun Group Intravenous Solutions Product Portfolio
  12. 8.2.5 Kelun Group Recent Developments
  13. 8.3 Fresenius Kabi
  14. 8.3.1 Fresenius Kabi Company Information
  15. 8.3.2 Fresenius Kabi Business Overview
  16. 8.3.3 Fresenius Kabi Intravenous Solutions Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Fresenius Kabi Intravenous Solutions Product Portfolio
  18. 8.3.5 Fresenius Kabi Recent Developments
  19. 8.4 Otsuka
  20. 8.4.1 Otsuka Company Information
  21. 8.4.2 Otsuka Business Overview
  22. 8.4.3 Otsuka Intravenous Solutions Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Otsuka Intravenous Solutions Product Portfolio
  24. 8.4.5 Otsuka Recent Developments
  25. 8.5 ICU Medical
  26. 8.5.1 ICU Medical Company Information
  27. 8.5.2 ICU Medical Business Overview
  28. 8.5.3 ICU Medical Intravenous Solutions Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 ICU Medical Intravenous Solutions Product Portfolio
  30. 8.5.5 ICU Medical Recent Developments
  31. 8.6 Fresenius Kabi
  32. 8.6.1 Fresenius Kabi Company Information
  33. 8.6.2 Fresenius Kabi Business Overview
  34. 8.6.3 Fresenius Kabi Intravenous Solutions Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Fresenius Kabi Intravenous Solutions Product Portfolio
  36. 8.6.5 Fresenius Kabi Recent Developments
  37. 8.7 JW Life Science
  38. 8.7.1 JW Life Science Company Information
  39. 8.7.2 JW Life Science Business Overview
  40. 8.7.3 JW Life Science Intravenous Solutions Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 JW Life Science Intravenous Solutions Product Portfolio
  42. 8.7.5 JW Life Science Recent Developments
  43. 8.8 B. Braun Melsungen
  44. 8.8.1 B. Braun Melsungen Company Information
  45. 8.8.2 B. Braun Melsungen Business Overview
  46. 8.8.3 B. Braun Melsungen Intravenous Solutions Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 B. Braun Melsungen Intravenous Solutions Product Portfolio
  48. 8.8.5 B. Braun Melsungen Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Intravenous Solutions Value Chain Analysis
  2. 9.1.1 Intravenous Solutions Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Intravenous Solutions Sales Mode & Process
  6. 9.2 Intravenous Solutions Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Intravenous Solutions Distributors
  9. 9.2.3 Intravenous Solutions Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst